The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy

Japanese Journal of Clinical Oncology

Volumn 41, Issue 11, 2011, Pages 1244-1250

  Wang, Ta I ^a   Wu, Po Kuei ^a,b,c   Chen, Cheng Feng ^a,b   Chen, Wei Ming ^a,b   Yen, Chueh Chuan ^a   Hung, Giun Yi ^a   Liu, Chien Lin ^a,b   Chen, Tain Hsiung ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Orthopedics sarcoma; Orthopedics sarcoma med; Orthopedics sarcoma surg

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; CANCER GRADING; CANCER RECURRENCE; CHILD; DIAGNOSTIC ERROR; FEMALE; FEMUR HEAD NECROSIS; FRACTURE; HUMAN; KNEE MENISCUS RUPTURE; LIMB SALVAGE; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT PLANNING; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIMB SALVAGE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 80155136816     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyr138     Document Type: Article

References (18)

1. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995;75:2186-95.
2. Ayerza MA, Muscolo DL, Aponte-Tinao LA, Farfalli G. Effect of erroneous surgical procedures on recurrence and survival rates for patients with osteosarcoma. Clin Orthop Relat Res 2006;452:231-5.
3. Rosen G, Murphy ML, Huvos AG, Gutierrez M, Marcove RC. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 1976;37:1-11.
4. Chen WM, Chen TH, Huang CK, Chiang CC, Lo WH. Treatment of malignant bone tumours by extracorporeally irradiated autograft-prosthetic composite arthroplasty. J Bone Joint Surg Br 2002;84:1156-61.
5. Bacci G, Ferrari S, Lari S, Mercuri M, Donati D, Longhi A, et al. Osteosarcoma of the limb. J Bone Joint Surg Br 2002;84:88-92.
6. Hawkins D, Arndt CA. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer 2003;98:2447-56.
7. Sluga M, Windhager R, Lang S, Heinzl H, Bielack S, Kotz R. Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma. Clin Orthop Relat Res 1999;358:120-7.
8. Harris M, Hartley AL, Blair V, Birch SS, Banerjee AJ, Freemont J, et al. Sarcomas in north west England: histopathological peer review. Br J Cancer 1991;64:315-20.
9. Shiraki M, Enterline HT, Brooks JJ, Cooper NS, Hirschl S, Roth JA, et al. Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer 1989;64:484-90.
10. Presant CA, Russell WO, Alexander RW, Fu YS. Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J ClinOncol 1986;4:1658-61.
11. Arai E, Nishida Y, Tsukushi S, Wasa J, Ishiguro N. Clinical and treatment outcomes of planned and unplanned excisions of soft tissue sarcomas. Clin Orthop Relat Res 2010;468:3028-34.
12. Chandrasekar CR, Wafa H, Grimer RJ, Carter SR, Tillman RM, Abudu A. The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br 2008;90:203-8.
13. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
14. Bacci G, Ferrari S, Mercuri M, Bertoni F, Picci P, Manfrini M, et al. Predictive factors for local recurrence in osteosarcoma. Acta Orthop Scand 1998;69:230-6.
15. Bacci G, Forni C, Longhi A, Ferrari S, Mercuri M, Bertoni F, et al. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol 2007;96:118-23.
16. Kaste SC, Liu T, Billups CA, Daw NC, Pratt CB, Meyer WH. Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatr Blood Cancer 2004;43:723-8.
17. Wu PK, Chen WM, Chen CF, Lee OK, Haung CK, Chen TH. Primary osteogenic sarcoma with pulmonary metastasis. Clinical results and prognostic factors in 91 patients. Jpn J Clin Oncol 2009;39: 514-22.
18. Wu PK, Chen WM, Lee OK, Chen CF, Huang CK, Chen TH. The prognosis for patients with osteosarcoma who have received prior manipulative therapy. J Bone Joint Surg Br 2010;92: 1580-5.